Menu
Expert Opinion

Get A Second Opinion

The medical second opinion will be presented to you within 48 hours.
Home/Prof. Ergün Tozkoparan, M.D.

Prof. Ergün Tozkoparan, M.D.

DEPARTMENT : Pulmonary Medicine

PRIMARY LOCATION : Gayrettepe Florence Nightingale Hospital

LANGUAGES : English, Turkish

Medicalpark Keçiören Hospital
Medicalpark Gebze Hospital
Private Akhisar Doğuş Hospital
Private Alanya Anadolu Hospital
GATA Chest Diseases Department (Chairman)
GATA Chest Diseases Department (Professor)
GATA Department of Chest Diseases (Associate Professor)
GATA Department of Chest Diseases (Assistant Professor)
Marshal Çakmak Military Hospital
GATA, Çamlıca Chest Diseases Hospital
  • Interventional pulmonology 
  • Sarcodiosis and other interstitial lung diseases 
  • Tuberculosis and other opportunistic lung infections in immunocompromised individuals
  • Asthma and COPD 
  • Pleural diseases 
  • Palliative treatments in lung cancer 
2006
University of Texas, MD Anderson Cancer Center
Department of Chest Diseases, Interventional Pulmonology Unit
2000
Istanbul University Cerrahpaşa Faculty of Medicine
Ophthalmology \ Professor
1996
Gülhane Military Medical Academy (GATA)
Department of Chest Disease
1994
Istanbul University Cerrahpaşa Faculty of Medicine
Ophthalmology \ Associate Professor
1984
Istanbul University Cerrahpaşa Faculty of Medicine Ophthalmology Specialization Training
1982
Gülhane Military Medical Faculty

1. The impact of sedation type on diagnostic yield of EBUS-TBNA: Looking from another point of view Gümüş S, Kaya H, Turhan  U, Özkısa T, Tozkoparan E. Clin Respir J. 2016 Jul 16. doi: 10.1111/crj.12532. [Epub ahead of print]. 

2. Effects of radiological extent on neutrophil/lymphocyte ratio in pulmonary sarcoidosis.Ocal N, Dogan D, Ocal R, Tozkoparan E,  Deniz O, Ucar E, Gumus S, Tasci C, Yildiz B, Taskin G, Taskin A, Badem S, Turhan U. Eur Rev Med Pharmacol Sci. 2016;20(4):709- 14. 

3. Paradoxical relationship between TNF-alpha antagonists and sarcoidosis. Baygin N.Tozkoparan E. Semin Arthritis Rheum. 2014  Apr;43(5):e2. doi:10.1016/j.semarthrit.2013.11.001. Epub 2013 Nov 13.. 

4. Response.Kaya H, Gümüş S, Uçar E, Aydoğan M, Muşabak U, Tozkoparan E, BilgiçH. Chest. 2013 Jan;143(1):274-5. doi:  10.1378/chest.12-2249.. 

5. The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in evaluating the responseto therapy in pulmonary and pleural  tuberculosis.Tascı C, Ozkaya S, Ozkara B, TozkoparanE, Ozkan M, Karadurmus N, Serdar M, Balkan A, Bilgic H.Onco Targets  Ther. 2012;5:385-90. doi: 10.2147/OTT.S32888. Epub 2012 Nov 22. 

6. Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia.Kaya H,Gümüş S, Uçar E, Aydoğan M, Muşabak U,  Tozkoparan E, Bilgiç H.Chest. 2012 Aug;142(2):513-6. doi: 10.1378/chest.11-1881. 

7. Serum chitotriosidase activity in pulmonary tuberculosis: response to treatment andcorrelations with clinical parameters. Cakır G, Gumus S, Ucar E, Kaya H, Tozkoparan E, Akgul EO, Karaman B, Deniz O, Kurt I, Ozkan M, Bilgic H.Ann Lab Med. 2012  May;32(3):184-9. doi: 10.3343/alm.2012.32.3.184. Epub 2012 Apr 18. 

8. Pulmonary Rehabilitation Using Modified Threshold Inspiratory Muscle Trainer (IMT) in Patients with Tetraplegia.Yasar F, Tasci  C, Savci S,Tozkoparan E, Deniz O, Balkan A, Bilgic H. Case Rep Med. 2012;2012:587901. doi: 10.1155/2012/587901. Epub 2012  Mar 26. 

9. Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in  patients with silicosis due to denim sandblasting.Deniz O, Gumus S, Ors F, Yaman H, Battal B, Karaman B, Acikel CH, Ucar E,  Cakir E, Tozkoparan E, Bilgic H. Clin Chem Lab Med. 2012 Jan 31;50(3):483-8. doi: 10.1515/cclm.2011.795. 

10. Serum prolidase activity in patients with pulmonary tuberculosis. Gumus S, Yaman H, Ozcan O, Deniz O, Karaman B, Cakir E,  Tozkoparan E, Ozkan M, Bilgic H. Scand J Clin Lab Invest. 2011 Oct;71(6):467-72. doi: 10.3109/00365513.2011.587021. Epub  2011 Jul 4. 

11. The role of oxidative stress and effect of alpha-lipoic acid in reexpansion pulmonary edema – an experimental study.Gumus  S, Yucel O, Gamsizkan M, Eken A, Deniz O,Tozkoparan E, Genc O, Bilgic H.Arch Med Sci. 2010 Dec;6(6):848-53. doi:10.5114/ aoms.2010.19290. Epub 2010 Dec 29. 

12. Effect of nail polish and henna on oxygen saturation determined by pulse oximetry in healthy young adult females.Sütçü  Çiçek H, Gümüs S, Deniz Ö, Yildiz S, Açikel CH, Çakir E,Tozkoparan E, Uçar E, Bilgiç H.Emerg Med J. 2011 Sep;28(9):783-5.  doi:10.1136/emj.2010.096073. Epub 2010 Oct 5. 

13. Proanthocyanidin to prevent formation of the reexpansion pulmonary edema.Yucel O, Ucar E, Tozkoparan E, Gunal A, Akay C,  Sahin MA, Genc OJ Cardiothorac Surg. Jul 2009 28;4:40. doi: 10.1186/1749-8090-4-40. 

14. Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential  antifungal therapy.Can MF, Yagci G, Gorenek L,Tozkoparan E, Ozerhan I, Cetiner S.Surg Infect (Larchmt). 2008 Feb;9(1):99-104.  doi:10.1089/sur.2006.094. Review. 

15. Changes in platelet count and indices in pulmonary tuberculosis.Tozkoparan E, Deniz O, Ucar E, Bilgic H, Ekiz K.Clin Chem Lab  Med. 2007;45(8):1009-13. 

16. High-resolution CT findings in patients with pulmonary tuberculosis: correlation with the degree of smear positivity.Ors F,  Deniz O, Bozlar U, Gumus S, Tasar M,Tozkoparan E, Tayfun C, Bilgic H, Grant BJ.J Thorac Imaging. 2007 May;22(2):154-9. 

17. Idiopathic pulmonary hemosiderosis in an adult patient responded well to corticosteroid therapy. Deniz O, Ongürü O, Ors F,  Gümüş S, Tozkoparan E, Bilgiç H, Ekiz K.Tuberk Thorax. 2007;55(1):77-82. 

18. Genetic diversity of Mycobacterium tuberculosis isolates at the Military Medical Academy in Ankara, Turkey. Kisa O, Albay A,  Baylan O, Tozkoparan E, Acikel CH, Doganci L. pic 

19. Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and  the degree of smear positivity in patients with pulmonary tuberculosis.Deniz O, Gumus S, Yaman H, Ciftci F, Ors F, Cakir E,  Tozkoparan E, Bilgic H, Ekiz K.Clin Biochem. 2007 Feb;40(3-4):162-6. Epub 2006 Nov 21. 

20. Primary nasolacrymal tuberculosis diagnosed after dacryocytorhinostomy.Tosun F, Tozkoparan E, Erdurman C, Ors F, Deniz O.  Auris Nasus Larynx. 2007 Jun;34(2):233-5. Epub 2006 Sep 29. 

21. Diagnostic value of leptin in tuberculous pleural effusions. Celik G, Kaya A, Poyraz B, Ciledag A, Elhan AH, Oktem A,  Tozkoparan E, Ozkan M.Int J Clin Pract. 2006 Nov;60(11):1437-42. epub

22. Reduced pulmonary function in wind instrument players.Deniz O, Savci S,Tozkoparan E, Ince DI, Ucar M, Ciftci F.Arch Med  Res. 2006 May;37(4):506-10. 

23. Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological  extent of disease in patients with community- acquired pneumonia.Deniz O, Tozkoparan E, Yaman H, Cakir E, Gumus S, Ozcan  O, Bozlar U, Bilgi C, Bilgic H, Ekiz K. Clin Biochem. 2006 Mar;39(3):287-92. Epub 2006 Feb 20. 

24. Atopy in patients with bronchiectasis: more than coincidence. Ozturk S, Tozkoparan E, Karaayvaz M, Caliskaner Z, Gulec M,  Deniz O, Ucar E, Ors F, Bozlar U. Tohoku J Exp Med. 2006 Jan;208(1):41-8. 

25. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease.Bozkanat E, Tozkoparan  E, Baysan O, Deniz O, Ciftci F, Yokusoglu M. J. Int Med Res. 2005 Sep-Oct;33(5):537-44. 

26. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy Tozkoparan E, Deniz  O, Cakir E, Yaman H, Ciftci F, Gumus S, Ozcan O, Akgul OE, Bilgic H, Erbil K, Ekiz K. Int J Tuberc Lung Dis. 2005 Sep;9(9):1040-5. 

27. High resolution computed tomographic features of pulmonary alveolar microlithiasis. Deniz O, Ors F, Tozkoparan E, Ozcan A,  Gumus S, Bozlar U, Bilgic H, Ekiz K, Demirci N. Euro J Radiol. 2005 Sep;55(3):452-60. 

28. The roles of HRCT and clinical parameters in assessing activity of suspected smear negative pulmonary tuberculosis.  Tozkoparan E, Deniz O, Ciftci F, Bozkanat E, Bicak M, Mutlu H, Ors F, Bilgic H, Demirci N. Arch Med Res. 2005 Mar Apr;36(2):166-70. 

29. Delay in the diagnosis of Turkish servicemen with pulmonary tuberculosis. He is the one who reads Kartaloglu Z, Cerrahoglu  K, Ilvan A, Tozkoparan E, Aydilek R. Mil Med. 2005 Mar;170(3):211- 

30. Low parathormone levels and hypercalcaemia in patients with pulmonary tuberculosis: relation to radiological extent of  disease and tuberculin skin test. Sea O, Tozkoparan E, Yonem A, Ciftci F, Bozkanat E, Cakir E, Ozcan O, Narin Y, Bilgic H, Ekiz K,  Demirci N. Int J Tuberc Lung Dis. 2005 Mar;9(3):317-21. 

31. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Cakir E, Deniz O, Ozcan O, Tozkoparan E,  Yaman H, Akgul EO, Bilgi C, Bilgic H, Ekiz K, Erbil MK. Clin Biochem. 2005 Mar;38(3):234-8. 

32. The incidence of tuberculosis in the armed forces: a good reflection of the whole population Ciftci F, Tozkoparan E, Deniz O,  Bozkanat E, Kibaroglu E, Demirci N. Int J Tuberc Lung Dis. 2004 Aug;8(8):965-8. 

33. Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis Yuksekol I, Ozkan M, Akgul  O, Tozkoparan E, Al-Rashed M, Balkan A, Hatipoglu K, Bilgic H, Erbil K, Demirci N. Int J Tuberc Lung Dis. 2003 Aug;7(8):771-6. 

34. Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement Köylü R, Tozkoparan  E, Pabuşçu Y, Ciftçi F, Bilgiç H, Seber O. IntJ Tuberc Lung Dis. 1997 Oct;1(5):474-6